Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults.

Clinical rheumatology - 1 May 2018

Gupta Latika, Chaurasia Smriti, Srivastava Puja, Dwivedi Sanjay, Lawrence Able, Misra Ramnath

Abstract excerpt

We studied the serum levels of B cell survival factors BAFF and APRIL in patients with idiopathic inflammatory myositis (IIM) and their relation with clinical and autoantibodies. Seventy-five patients (51 females and 24 males) with IIM (Bohan and Peter's criteria 1975) and 25 healthy adults were analyzed for BAFF, APRIL and IL-17 by ELISA, and myositis-specific and associated antibodies (MSA and MAA) using line...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Cell Activating Factor
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Interleukin-17

Share to Myositis

Share to Phenotype

Source

Identifiers

PMID: 29516280
DOI: 10.1007/s10067-018-4046-x

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults.PMID 29516280Read ↗

Autoantibody-Based Clinicoradiopathologic Phenotyping of Idiopathic Inflammatory Myopathies: An Indian Cohort.Semantic proximity Read ↗

Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.Semantic proximity Read ↗

Spectrum of clinical phenotypes associated with myositis-specific and myositis-associated antibodies in juvenile idiopathic inflammatory myositis: Our experience from North India.Semantic proximity Read ↗

Update in juvenile myositis.Semantic proximity Read ↗

The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.Semantic proximity Read ↗

Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile MyositisSemantic proximity Read ↗

B Cell Lymphocytosis in Juvenile DermatomyositisSemantic proximity Read ↗

IFN-β plasmatic levels are best predictors of muscle disease activity than IFN-α in a longitudinal cohort of patients with juvenile dermatomyositisSemantic proximity Read ↗

Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes.Semantic proximity Read ↗

The complexity of the BAFF TNF-family members: implications for autoimmunity.Semantic proximity Read ↗

Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents.Semantic proximity Read ↗

Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.